Carrier for medicaments for obtaining oral bioavailability
Details for Australian Patent Application No. 2005266739 (hide)
International Classifications
Event Publications
8 February 2007 PCT application entered the National Phase
PCT publication WO2006/010360 Priority application(s): WO2006/010360
25 June 2009 Section 223 Application Allowed
Biotecon Therapeutics GmbH The time in which to request examination has been extended to 14 Jun 2009. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005 2006
25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005266755-2, 2-bipyridine ligand, sensitizing dye and dye sensitized solard cell
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser